FindTrial
Sign In

Placebo double encapsulated oral transplant of fecal microbiota

DRUG5 trials

Sponsors

Assistance Publique Hopitaux De Paris

Conditions

Adults Non Diabete Remission (NDR) Type 2 Diabete (T2D) patients 1 to 5 years after bariatric surgeryCrohn’s diseasePatients colonized with MDR-GNBPrimary Sclerosing CholangitisSevere Irritable Bowel Syndrome (IBS)

Phase 2

Fecal microbiota transplantation for primary sclerosing cholangitis - randomized study versus sham transplantation (FMT-SCLER).
Not yet recruitingCTIS2023-505469-95-00
Assistance Publique Hopitaux De ParisPrimary Sclerosing Cholangitis
Target: 72Updated: 2025-12-02

Phase 3

ICEBOAT. A prospective, multi-center, double blind randomized trial of fecal microbiota transplantation (FMT) delivered by capsule versus placebo in severe irritable bowel syndrome (IBS)
Not yet recruitingCTIS2024-516099-13-00
Assistance Publique Hopitaux De ParisSevere Irritable Bowel Syndrome (IBS)
Target: 150Updated: 2025-05-21
Fecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawal (MIRACLE)
RecruitingCTIS2024-511822-30-00
Assistance Publique Hopitaux De ParisCrohn’s disease
Start: 2021-09-22Target: 350Updated: 2025-07-15
Diabete RemIssion using Fecal TransfER post bariatric surgery (DRIFTER)
RecruitingCTIS2024-511870-65-00
Assistance Publique Hopitaux De ParisAdults Non Diabete Remission (NDR) Type 2 Diabete (T2D) patients 1 to 5 years after bariatric surgery
Start: 2024-01-16Target: 94Updated: 2024-11-06
FECES - Fecal transplantation to Eradicate Colonizing Emergent Superbugs
Not yet recruitingCTIS2024-516393-29-00
Assistance Publique Hopitaux De ParisPatients colonized with MDR-GNB
Target: 299Updated: 2025-05-09